Clinical Trial Update: A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized Trial to Evaluate Efficacy & Safety in Anemia Subjects [Phase 3]

View source ↗

Summary

The document notes the completion of a Phase 3 double-blind, double-dummy trial in iron deficiency anemia and that the results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Snippet

Sponsor: Sanol GmbH | Conditions: Iron Deficiency Anemia | Phase 3 | Status: COMPLETED | Results posted: 2014-11-06